DEBIOPHARM AND ASPEN PARTNER TO LAUNCH PROSTATE CANCER DRUG TR...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
LAUSANNE, Switzerland and DURBAN, South Africa, Feb. 1, 2022, /PRNewswire-AsiaNet/ -- Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company and Aspen, a South African headquartered multinational pharmaceutical company announced today their partnership tolaunch Trelstar(R) (Triptorelin) in South Africa for the treatme...
Authors: LATEST ASIANET NEWS RELEASES